Today is another big milestone for Philly\'s Cellicon ValleyFirst FDA approved CART therapy Novartis PennFirst FDA approved gene therapy sparktx ChildrensPhila>$450M invested in cellgene tx mfg$ONCE to be acquired by Roche but will co

Today is another big milestone for Philly's “Cellicon Valley” First FDA approved CAR-T therapy @Novartis @Penn First FDA approved gene therapy @spark_tx @ChildrensPhila >$450M invested in cell/gene tx mfg $ONCE to be acquired by @Roche but will co

Today is another big milestone for Philly's “Cellicon Valley” First FDA approved CAR-T therapy @Novartis @Penn First FDA approved gene therapy @spark_tx @ChildrensPhila >$450M invested in cell/gene tx mfg $ONCE to be acquired by @Roche but will continue to operate in Philly pic.twitter.com/0WhOqWe26r

More From BioPortfolio on "Today is another big milestone for Philly's “Cellicon Valley” First FDA approved CAR-T therapy @Novartis @Penn First FDA approved gene therapy @spark_tx @ChildrensPhila >$450M invested in cell/gene tx mfg $ONCE to be acquired by @Roche but will co"